| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.04 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.04 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.04 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.04 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.04 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.04 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.071 | 0.04 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | 0.1 | 0.04 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.068 | 0.05 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.092 | 0.05 |